MB-PhD studentship allows aspiring clinical scientists and academics to undertake medical degree training in tandem with the research expertise of a PhD in Cancer Sciences, leading to the joint award of an MBChB and PhD.
Why do an MB-PhD?
- Graduate with an MBChB and a PhD
- Have your PhD and undergraduate MBChB fees paid*
- Receive an annual stipend to help with your living costs
- Gain the skills, knowledge and training to drive new innovations in clinical care and become a future cancer research leader
- Receive mentorship and training from world-leading academic clinicians and cancer scientists
Eligibility criteria
To apply to intercalate onto the PhD in Cancer Sciences component of the MB-PhD, you must meet the below criteria and satisfy the general requirements for permission to intercalate set by your institution, including passing all components of the MBChB at first attempt in the year prior to intercalation.
A University of Manchester MBChB student
- holding a BSc (hons) 2.1 or above in a relevant subject and in year 2 or year 3 of the MBChB or year 1 or year 2 of GEM; or
- currently studying in year 3 of the MBChB or year 2 of GEM
A University of St Andrews Medicine BSc (Hons) student on the Manchester course pathway:
- holding or predicted a BSc (hons) 2.1 or above and be intending to intercalate straight onto the MB-PhD ahead of your arrival in Manchester or by no later than between year 3 and year 4 of the Manchester MBChB programme
A University of Leeds MBChB student:
- currently studying in year 3 of the MB ChB
International applicants (including EU nationals) must ensure they meet the relevant academic eligibility criteria (including English Language).
